These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 37730669)

  • 1. A Novel pyroptosis-related signature for predicting prognosis and evaluating tumor immune microenvironment in ovarian cancer.
    Yang J; Wang C; Zhang Y; Cheng S; Xu Y; Wang Y
    J Ovarian Res; 2023 Sep; 16(1):196. PubMed ID: 37730669
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel autophagy-related gene signature associated with prognosis and immune microenvironment in ovarian cancer.
    Yang J; Wang C; Zhang Y; Cheng S; Wu M; Gu S; Xu S; Wu Y; Wang Y
    J Ovarian Res; 2023 Apr; 16(1):86. PubMed ID: 37120633
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anoikis-related signature predicts prognosis and characterizes immune landscape of ovarian cancer.
    Yang J; Zhang Y; Cheng S; Xu Y; Wu M; Gu S; Xu S; Wu Y; Wang C; Wang Y
    Cancer Cell Int; 2024 Feb; 24(1):53. PubMed ID: 38310291
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Construction and validation of a novel ferroptosis-related signature for evaluating prognosis and immune microenvironment in ovarian cancer.
    Yang J; Wang C; Cheng S; Zhang Y; Jin Y; Zhang N; Wang Y
    Front Genet; 2022; 13():1094474. PubMed ID: 36685851
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Pyroptosis-Related Gene Signature Predicts Prognosis and Tumor Immune Microenvironment in Colorectal Cancer.
    Li L; Li Y; Lin J; Pang W
    Technol Cancer Res Treat; 2024; 23():15330338241277584. PubMed ID: 39155627
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combination of ferroptosis and pyroptosis to construct a prognostic classifier and predict immune landscape, chemotherapeutic efficacy and immunosuppressive molecules in hepatocellular carcinoma.
    Xu L; Zheng Q; Liu W
    BMC Cancer; 2022 Mar; 22(1):229. PubMed ID: 35236323
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pyroptosis related genes signature predicts prognosis and immune infiltration of tumor microenvironment in hepatocellular carcinoma.
    Fang G; Zhang Q; Fan J; Li H; Ding Z; Fu J; Wu Y; Zeng Y; Liu J
    BMC Cancer; 2022 Sep; 22(1):999. PubMed ID: 36127654
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical significance and immune infiltration analyses of a novel coagulation-related signature in ovarian cancer.
    Yang J; Wang C; Zhang Y; Cheng S; Wu M; Gu S; Xu S; Wu Y; Sheng J; Voon DC; Wang Y
    Cancer Cell Int; 2023 Oct; 23(1):232. PubMed ID: 37803446
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comprehensive genomic signature of pyroptosis-related genes and relevant characterization in hepatocellular carcinoma.
    Wang S; Gao S; Shan L; Qian X; Luan J; Lv X
    PeerJ; 2023; 11():e14691. PubMed ID: 36650832
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of a pyroptosis-related prognostic signature in breast cancer.
    Chen H; Luo H; Wang J; Li J; Jiang Y
    BMC Cancer; 2022 Apr; 22(1):429. PubMed ID: 35443644
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A risk model based on pyroptosis subtypes predicts tumor immune microenvironment and guides chemotherapy and immunotherapy in bladder cancer.
    Wu T; Li S; Yu C; Wu Y; Long H
    Sci Rep; 2022 Dec; 12(1):21467. PubMed ID: 36509838
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The fatty acid-related gene signature stratifies poor prognosis patients and characterizes TIME in cutaneous melanoma.
    Hua S; Wang W; Yao Z; Gu J; Zhang H; Zhu J; Xie Z; Jiang H
    J Cancer Res Clin Oncol; 2024 Jan; 150(2):40. PubMed ID: 38279987
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel defined risk signature based on pyroptosis-related genes can predict the prognosis of prostate cancer.
    Hu D; Cao Q; Tong M; Ji C; Li Z; Huang W; Jin Y; Tong G; Wang Y; Li P; Zhang H
    BMC Med Genomics; 2022 Feb; 15(1):24. PubMed ID: 35135561
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identifying a Novel Defined Pyroptosis-Associated Long Noncoding RNA Signature Contributes to Predicting Prognosis and Tumor Microenvironment of Bladder Cancer.
    Lu H; Wu J; Liang L; Wang X; Cai H
    Front Immunol; 2022; 13():803355. PubMed ID: 35154117
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Establishment of an ovarian cancer omentum metastasis-related prognostic model by integrated analysis of scRNA-seq and bulk RNA-seq.
    Zhang D; Lu W; Cui S; Mei H; Wu X; Zhuo Z
    J Ovarian Res; 2022 Nov; 15(1):123. PubMed ID: 36424614
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of a pyroptosis-associated long non-coding RNA signature for predicting the immune status and prognosis in skin cutaneous melanoma.
    Wu L; Liu G; He YW; Chen R; Wu ZY
    Eur Rev Med Pharmacol Sci; 2021 Sep; 25(18):5597-5609. PubMed ID: 34604952
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessing of programmed cell death gene signature for predicting ovarian cancer prognosis and treatment response.
    Lian X; Liu B; Wang C; Wang S; Zhuang Y; Li X
    Front Endocrinol (Lausanne); 2023; 14():1182776. PubMed ID: 37342266
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification and validation of pyroptosis-related gene landscape in prognosis and immunotherapy of ovarian cancer.
    Gao L; Ying F; Cai J; Peng M; Xiao M; Sun S; Zeng Y; Xiong Z; Cai L; Gao R; Wang Z
    J Ovarian Res; 2023 Jan; 16(1):27. PubMed ID: 36707884
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Construction of a prognostic risk model based on pyroptosis-related genes and comprehensive analysis of key genes and tumor immune microenvironment for colon cancer.
    Liu M; Zhang J; Zhao Y; Zhang X
    Medicine (Baltimore); 2024 Sep; 103(36):e39300. PubMed ID: 39252305
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Novel Pyroptosis-Related Gene Signature for Predicting the Prognosis and the Associated Immune Infiltration in Colon Adenocarcinoma.
    Chen Z; Han Z; Nan H; Fan J; Zhan J; Zhang Y; Zhu H; Cao Y; Shen X; Xue X; Lin K
    Front Oncol; 2022; 12():904464. PubMed ID: 35912258
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.